Business Wire

Ultivue Expands UltiMapper™ Portfolio of Multiplex Marker Assays for Comprehensive Phenotyping of the Immune Microenvironment and Tissue Immuno-Profiling Research

Share

Ultivue, a leading developer of tissue biomarker identification and quantification assays for translational research and pathology labs, today announced the expansion of its UltiMapper™ multiplex immunofluorescence kit portfolio with a T-reg and MDSC kit. The UltiMapper I/O T-reg kit identifies regulatory T cells and cytotoxic T cells within the tumor context and allows for the phenotyping of activated double positive T cells. The UltiMapper I/O MDSC kit enables the identification and characterization of myeloid derived suppressor cells and allows researchers to differentiate M-MDSC from PMN-MDSC phenotypes.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191106005226/en/

TMA of colorectal cancer stained with UltiMapper I/O MDSC kit (CD11b green, CD14 red, CD15 magenta, HLA-DR cyan) (Photo: Business Wire)

TMA of colorectal cancer stained with UltiMapper I/O MDSC kit (CD11b green, CD14 red, CD15 magenta, HLA-DR cyan) (Photo: Business Wire)

The new kits have the same benefits of high-throughput whole-slide imaging using conventional IHC equipment and workflows as the previously released UltiMapper I/O PD-L1, UltiMapper I/O PD-1, UltiMapper I/O T-act, and UltiMapper I/O APC kits. “The addition of the T-reg and MDSC kits to the UltiMapper platform now provides researchers with an in-depth view of the sources of overall cell regulation and suppression critical in characterizing the signatures at play within the tumor microenvironment,” said Philippe Mourere, Senior VP of Commercial Operations at Ultivue. “We are very encouraged that the increased breadth and depth of immuno-profiling markers in tissue samples will support further validation of clinically-relevant biomarkers in immuno-oncology, inflammation & immunology, and cancer research.”

Research featuring data generated by the MDSC and T-reg kits will be presented in three of a total of ten posters showcasing the Ultivue technology at the upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting at The Gaylord National Resort & Convention Center in National Harbor, MD, November 6-10.

Details of the poster sessions can be found below:

Friday, November 8, 7am – 8pm:

P39: Looking beyond the assay: Comparison of multiplex chromogenic and fluorescent IHC for standardized immune oncology profiling in non-small cell lung carcinoma patients

P45: Multiplex IF staining, whole-slide imaging, and spatial phenotyping of T-cell exhaustion, T-regs, and MDSCs in Tumor FFPE samples

P49: Use of Ultivue ISP mIF to localize and quantify T-regs in human FFPE tissue

P55: Combining the best of 2 worlds: Transfer of mIF images from NSCLC patients into pseudo-chromogenic mIHC images

P127: Development of a 12-plex mIF panel for in depth investigation of the TIME landscape analyzing 4,096 phenotypes

P563: Profiling T-reg and CTL relationships in the TME of NSCLC FFPE samples

P567: Characterizing MDSCs in the TME of CRC FFPE samples

Saturday, November 9, 7am – 8:30pm:

P40: Tumor immunity signatures to expand current Dx approaches in MMR-deficient cancers in the context of Lynch Syndrome through ISP technology and Tissue Phenomics integration

P46: Same-slide mIF and brightfield histological staining as a new research tool for fast and comprehensive pathology assessment of the TME

P70: Tissue-based characterization of T-cell exhaustion in IBD and CRC using mIHC

Ultivue’s scientific team welcomes the opportunity to interact with the biomedical community during the SITC Annual Meeting at booth #428.

About Ultivue

By developing a single set of novel, proprietary reagents used both for biomarker discovery (higher content, low throughput) and translational use (lower content, high throughput), Ultivue is connecting the insights gained from research directly into the pathology lab. Ultivue’s UltiMapper multiplexed assays applied to tissue biopsy samples enable simultaneous quantitation of multiple biomarkers with sub-cellular spatial resolution and fit completely within traditional IHC workflows. Translational and clinical researchers leverage UltiMapper assays to elucidate complex biology and demonstrate their clinical utility as precision medicine research tools. Ultivue is expanding its UltiMapper assay product portfolio and menu of contract research services to provide a comprehensive set of precision medicine solutions for oncology research and focus in other therapeutic areas.

Ultivue is based in Cambridge, MA. For more information, visit www.ultivue.com

For Research Use Only. Not for use in diagnostic procedures.

Contact information

Louis Levy
Director, Business & Corporate Development
+1-617-945-2662
contact@ultivue.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Asahi Kasei Providing Samples of Hyaluronic Acid Nanogel as a New Pharmaceutical Excipient5.8.2020 05:00:00 EESTPress release

Asahi Kasei has established industrial manufacturing technology for hyaluronic acid (HA) nanogel* as a new pharmaceutical excipient, and is providing samples to prospective customers in order to commercialize the product. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200804005334/en/ Chemical structure and self-assembly of HA nanogel (Graphic: Business Wire) The Functional Additives Division of Asahi Kasei’s Specialty Solutions SBU supplies Ceolus™ microcrystalline cellulose to pharmaceutical manufacturers around the world for use as an excipient for drug tablets. The commercialization of HA nanogel would expand the product lineup by adding a drug delivery system (DDS) base material for injection formulations. HA nanogel is expected to improve the quality of life (QOL) for patients by enabling the low-toxicity solubilization of insoluble drugs, facilitating the formulation of biopharmaceuticals such as proteins and peptides

RoboSense 80 Laser-Beam LiDAR RS-Ruby Lite Is Officially for Sale, Early-Bird Price $12,8004.8.2020 21:00:00 EESTPress release

RoboSense http://www.robosense.ai/, the leading provider of smart LiDAR sensor, today launched an 80 laser-beam 3D sensing LiDAR ready for customer delivery with early-bird price of $12,800 (limited offer till 31st August, 2020), and standard price of $15,800. The timing of announcing this favorable package also marks the company's 6-year anniversary. The performance of the RS-Ruby Lite is close to that of the 128 laser-beam LiDAR RS-Ruby, with a vertical angular resolution of 0.1 degrees and 160m@10% ranging ability (with the longest detection range of 230 meters), making it suitable to address medium-and-high-speed autonomous driving applications with a price much more affordable to accelerate the commercialization of smart and safe transportation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200804005578/en/ The RS-Ruby Lite’s on-vehicle road-test point cloud image (Photo: Business Wire) Inheriting The Superb Performanc

Andersen Global Enters Chile With the Addition of Two Collaborating Firms4.8.2020 16:30:00 EESTPress release

Andersen Global enters the Chilean market through Collaboration Agreements with two Santiago-based firms: law firm Chirgwin Peñafiel and tax firm SPASA Consulting. The firms are in close partnership with each other and add depth and breadth to the organization’s Latin American platform as it continues its steady expansion. Founded in 2009, Chirgwin Peñafiel, led by Office Managing Partner Andrés Chirgwin, is a full-service law firm specializing in commercial and corporate law, M&A, energy, labor law and banking & finance. The firm works with a variety of corporate clients, being strongly focused on providing legal support to multinational companies with operations in Chile, while also assisting Chilean-based companies with local and international legal needs. Chirgwin Peñafiel has been recognized by IFLR1000, Leaders League and Best Lawyers. “Our firm is committed to delivering quality, comprehensive solutions to our local and international clients,” Andrés said. “Andersen Global’s cap

Lam Research and VELO3D Strike Strategic Agreement to Use Metal Additive Manufacturing Applications for Production of Semiconductor Capital Equipment4.8.2020 16:25:00 EESTPress release

Digital manufacturing innovator VELO3D and Lam Research Corporation (Nasdaq: LRCX) today announced a joint development agreement that includes collaboration on novel materials and designs in metal additive manufacturing (AM) or 3D printing applications for the semiconductor industry. Lam plans to significantly increase the volume of parts produced by AM over the next five years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200804005187/en/ The VELO3D Sapphire 3D metal printer (Photo: Business Wire) Additive manufacturing allows transformation of the supply chain from production of parts typically manufactured by subtractive methods, to higher performance, innovative designs that enable agile supply chains to adopt Industry 4.0 principles. VELO3D will develop new metal alloys on its Sapphire® printer that are critical to Lam designs and technologies. Lam Capital will also invest an undisclosed amount in VELO3D. “Lam Researc

Latest Generation YellowScan Mapping Systems Rely on Velodyne Lidar Sensors to Meet Demanding Needs of Survey Professionals4.8.2020 15:00:00 EESTPress release

Velodyne Lidar, Inc. today announced two new generation YellowScan mobile mapping systems use Velodyne’s lidar sensors to help achieve the high precision and accuracy needed in aerial 3D mapping. Velodyne’s powerful lidar sensors generate real-time georeferenced point cloud data that allows YellowScan systems to accurately measure and analyze an area so customers can avoid time-intensive, costly manual surveys. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200804005168/en/ The YellowScan Surveyor Ultra is a high density and long range mapping solution equipped with a Velodyne Ultra Puck™ sensor. (Photo: YellowScan) The YellowScan Surveyor Ultra is a high density and long range mapping solution equipped with a Velodyne Ultra Puck™ sensor and ideally suited for high speed unmanned aerial vehicles (UAV), such as VTOL and helicopter drones. The YellowScan Surveyor is the company’s lightest system – at 1.6 kg including the batte

Imricor Announces First Sales Collaboration With Philips4.8.2020 15:00:00 EESTPress release

Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the worldwide leader in MRI-guided cardiac ablation products, is pleased to announce the first sales collaboration with Philips, a global leader in healthcare technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200804005317/en/ Imricor announces first sales partnership with Philips. (Photo: Business Wire) The sales collaboration provides Philips non-exclusive rights to re-sell Imricor’s Advantage-MR System, along with Philips’ industry-leading MRI scanners in European countries that recognize the CE mark. This agreement is the first such agreement signed by Imricor. Imricor’s Chair and CEO, Steve Wedan said: “This agreement is a major milestone for Imricor, allowing Philips to take the lead on driving iCMR lab adoption and enabling us to focus on supporting utilization, growing our portfolio of consumable devices and expanding our indications for use. In thi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom